{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:15:13Z","timestamp":1791213313575,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010799","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hospital for Tropical Diseases Charitable Fund"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Leprosy is rare in the United Kingdom (UK), but migration from endemic countries results in new cases being diagnosed each year. We documented the clinical presentation of leprosy in a non-endemic setting.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Demographic and clinical data on all new cases of leprosy managed in the Leprosy Clinic at the Hospital for Tropical Diseases, London between 1995 and 2018 were analysed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>157 individuals with a median age of 34 (range 13\u201385) years were included. 67.5% were male. Patients came from 34 different countries and most contracted leprosy before migrating to the UK. Eighty-two (51.6%) acquired the infection in India, Sri Lanka, Bangladesh, Nepal and Pakistan. 30 patients (19.1%) acquired leprosy in Africa, including 11 from Nigeria. Seven patients were born in Europe; three acquired their leprosy infection in Africa, three in South East Asia, and one in Europe. The mean interval between arrival in the UK and symptom onset was 5.87 years (SD 10.33), the longest time to diagnosis was 20 years.<\/jats:p>\n<jats:p>Borderline tuberculoid leprosy (n = 71, 42.0%), and lepromatous leprosy (n =, 53 33.1%) were the commonest Ridley Jopling types. Dermatologists were the specialists diagnosing leprosy most often. Individuals were treated with World Health Organization recommended drug regimens (rifampicin, dapsone and clofazimine).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Leprosy is not a disease of travellers but develops after residence in an leprosy endemic area. The number of individuals from a leprosy endemic country reflect both the leprosy prevalence and the migration rates to the United Kingdom. There are challenges in diagnosing leprosy in non-endemic areas and clinicians need to recognise the symptoms and signs of leprosy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0010799","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:41:29Z","timestamp":1666291289000},"page":"e0010799","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Diagnosing and treating leprosy in a non-endemic setting in a national centre, London, United Kingdom 1995\u20132018"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-8966","authenticated-orcid":true,"given":"Diana N.","family":"Lockwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Checkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"issue":"9416","key":"pntd.0010799.ref001","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"WJ Britton","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"pntd.0010799.ref002","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"DS Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"pntd.0010799.ref003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.epirev.a036245","article-title":"Leprosy: the epidemiology of a slow bacterium","volume":"4","author":"PE Fine","year":"1982","journal-title":"Epidemiol Rev"},{"key":"pntd.0010799.ref004","first-page":"417","volume":"95","author":"Global Leprosy (Hansen\u2019s Disease) update, 2019: time to step up prevention initiatives","year":"2020","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0010799.ref005","author":"World-Health-Organisation","year":"2002","journal-title":"Report on the third meeting of the WHO Technical advisory group on elimination of leprosy"},{"key":"pntd.0010799.ref006","volume-title":"Pathogenesis of Leprosy and Related Diseases","author":"DS Ridley","year":"1988"},{"issue":"12","key":"pntd.0010799.ref007","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jclinpath-2020-206546","article-title":"Utility of an infectious and tropical disease histopathology diagnostic review service","volume":"73","author":"SYP Yue","year":"2020","journal-title":"J Clin Pathol"},{"issue":"2","key":"pntd.0010799.ref008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clindermatol.2006.05.012","article-title":"Leprosy","volume":"25","author":"SL Walker","year":"2007","journal-title":"Clin Dermatol"},{"issue":"1","key":"pntd.0010799.ref009","first-page":"9","article-title":"Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation?","volume":"65","author":"C Lienhardt","year":"1994","journal-title":"Lepr Rev"},{"issue":"9","key":"pntd.0010799.ref010","doi-asserted-by":"crossref","first-page":"e0004065","DOI":"10.1371\/journal.pntd.0004065","article-title":"ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum","volume":"9","author":"SL Walker","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0010799.ref011","doi-asserted-by":"crossref","first-page":"e2440","DOI":"10.1371\/journal.pntd.0002440","article-title":"A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction","volume":"7","author":"CG Voorend","year":"2013","journal-title":"PLoS Neglected Tropical Diseases [electronic resource]"},{"issue":"4","key":"pntd.0010799.ref012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/qjmed\/94.4.207","article-title":"The diagnosis of leprosy is delayed in the United Kingdom","volume":"94","author":"DN Lockwood","year":"2001","journal-title":"QJM"},{"key":"pntd.0010799.ref013","volume-title":"Multidrug therapy against leprosy: development and implementation over the past 25 years","author":"World Health Organization","year":"2004"},{"issue":"6","key":"pntd.0010799.ref014","first-page":"515","article-title":"Impact of leprosy on the quality of life","volume":"77","author":"GA Joseph","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"7","key":"pntd.0010799.ref015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hci079","article-title":"Leprosy in Britain: 50 years experience in Liverpool","volume":"98","author":"AL Gill","year":"2005","journal-title":"Qjm"},{"issue":"5","key":"pntd.0010799.ref016","doi-asserted-by":"crossref","first-page":"e010608","DOI":"10.1136\/bmjopen-2015-010608","article-title":"Leprosy in England and Wales 1953\u20132012: surveillance and challenges in low incidence countries","volume":"6","author":"N Fulton","year":"2016","journal-title":"BMJ Open"},{"issue":"696","key":"pntd.0010799.ref017","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/pgmj.59.696.652","article-title":"Leprosy in Birmingham\u2014a Review","volume":"59","author":"CJ Ellis","year":"1983","journal-title":"Postgrad Med J"},{"key":"pntd.0010799.ref018","volume-title":"Seventh Report","author":"Leprosy WHOECo","year":"1998"},{"key":"pntd.0010799.ref019","volume-title":"Skin Biopsy in Leprosy","author":"DS Ridley","year":"1977"},{"key":"pntd.0010799.ref020","first-page":"421","article-title":"Guidelines for slit skin smears","volume":"55","author":"WHO","year":"1987","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"pntd.0010799.ref021","first-page":"847","volume-title":"Chemotherapy of leprosy","author":"Leprosy WECo","year":"1994"},{"issue":"4","key":"pntd.0010799.ref022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.47276\/lr.76.4.277","article-title":"The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline","volume":"76","author":"WH Van Brakel","year":"2005","journal-title":"Lepr Rev"},{"issue":"1","key":"pntd.0010799.ref023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0363-5023(87)80189-2","article-title":"The repeatability of testing with Semmes-Weinstein monofilaments","volume":"12","author":"J Bell-Krotoski","year":"1987","journal-title":"J Hand Surg [Am]"},{"issue":"2","key":"pntd.0010799.ref024","first-page":"157","article-title":"Sensory functions in limbs of normal persons and leprosy patients with peripheral trunk damage","volume":"66","author":"GN Malaviya","year":"1994","journal-title":"Indian J Lepr"},{"issue":"1","key":"pntd.0010799.ref025","first-page":"28","article-title":"Reference values for touch sensibility thresholds in healthy Nepalese volunteers","volume":"67","author":"CM Kets","year":"1996","journal-title":"Lepr Rev"},{"issue":"2","key":"pntd.0010799.ref026","first-page":"115","article-title":"Reactions in borderline leprosy","volume":"74","author":"G Ramu","year":"2002","journal-title":"Indian J Lepr"},{"key":"pntd.0010799.ref027","volume-title":"Chemotherapy of leprosy for control programmes","author":"WHO","year":"1982"},{"key":"pntd.0010799.ref028","unstructured":"World Health Organization TLU, Division of Control of Tropical Diseases. Risk of relapse in leprosy. Geneva: 1994 Contract No.: WHO\/CTD\/LEP\/94.1."},{"key":"pntd.0010799.ref029","first-page":"1","article-title":"WHO Expert Committee on Leprosy","volume":"874","year":"1998","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"pntd.0010799.ref030","first-page":"55","article-title":"Leprosy in Toronto: an analysis of 184 imported cases","volume":"170","author":"AK Boggild","year":"2004","journal-title":"Can Med Assoc J"},{"issue":"2","key":"pntd.0010799.ref031","article-title":"Delayed Diagnosis, Leprosy Reactions, and Nerve Injury Among Individuals With Hansen\u2019s Disease Seen at a United States Clinic","volume":"3","author":"KE Leon","year":"2016","journal-title":"Open Forum Infect Di"},{"issue":"6","key":"pntd.0010799.ref032","doi-asserted-by":"crossref","first-page":"e1702","DOI":"10.1371\/journal.pntd.0001702","article-title":"Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy","volume":"6","author":"DN Lockwood","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010799.ref033","doi-asserted-by":"crossref","first-page":"221","DOI":"10.47276\/lr.87.2.221","article-title":"The use of steroids and thalidomide in the management of Erythema Nodosum Leprosum; 17 years at the Hospital for Tropical Diseases, London","volume":"87","author":"LEB Nabarro","year":"2016","journal-title":"Leposy Review"},{"issue":"1","key":"pntd.0010799.ref034","first-page":"8","article-title":"Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India","volume":"61","author":"DN Lockwood","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"1","key":"pntd.0010799.ref035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.47276\/lr.76.1.14","article-title":"The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India","volume":"76","author":"WH van Brakel","year":"2005","journal-title":"Lepr Rev"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010799","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:31:36Z","timestamp":1667323896000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010799"}},"subtitle":[],"editor":[{"given":"Mauro","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010799","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0010799","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}